Amyloid-β-driven Alzheimer's disease reshapes the colonic immune system in mice

淀粉样蛋白β驱动的阿尔茨海默病会重塑小鼠的结肠免疫系统。

阅读:3
作者:Priya Makhijani,Taylor R Valentino,Max Manwaring-Mueller,Rohini Emani,Wei-Chieh Mu,Carlos Galicia Aguirre,Christopher Ryan Tan,Anand Rane,Kenneth A Wilson,Alexander Kifle,Nan Chen,Huixun Du,Fei Wu,Jenny Hong Yu Ng,Benjamin D Ambrose,Prasanna Vadhana Ashok Kumaar,Saad Khan,Shawn Winer,Chao Wang,Arthur Mortha,David Furman,Birgit Schilling,Lisa M Ellerby,Olga L Rojas,Julie K Andersen,Daniel A Winer

Abstract

The "gut-brain axis" is an emerging target in Alzheimer's disease (AD), although its immunological features remain poorly understood. Using single-cell RNA sequencing, coupled to extensive spectral-tuning flow cytometry validation of the colon immune compartment in the 5XFAD amyloid-β mouse model, we found several AD-associated changes including in B/plasma cell activity. Notably, levels of CXCR4+ antibody-secreting cells are reduced in 5XFAD colons. This change corresponds with accumulating CXCR4+ B cells and gut-specific IgA+ cells in the brain and dura mater, respectively. Consistently, a chemokine ligand for CXCR4, CXCL12, is expressed at higher levels in the 5XFAD brain and in in silico-analyzed human AD brain studies, supporting altered neuroimmune trafficking. An inulin prebiotic fiber diet could expand gut IgA+ cells, rescue peripheral Treg levels, reduce dysbiosis, improve serum microbial metabolite levels, and attenuate overall AD-associated frailty. Our study reveals key aspects of the gut-brain axis and highlights potential targets against AD.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。